Henry A. Nasrallah, MD

Activity Chair

Henry A. Nasrallah, MD

  • Sydney W. Souers Professor
  • Chair, Department of Psychiatry and Behavioral Neuroscience
  • Saint Louis University School of Medicine
  • St. Louis, MO

Saturday, October 22, 2016

Sheraton Society Hill
One Dock Street
Philadelphia, PA

  • 7:30 am – 8:00 am
  • Registration and Breakfast
  • 8:00 am – 12:00 pm
  • CME-certified Activity

Program Overview

Schizophrenia is a severe and frequently debilitating mental illness, designated by the World Health Organization as one of the top 10 leading causes of disability worldwide. Schizophrenia is characterized by a chronic and relapsing course, with generally incomplete remissions, substantial functional decline, frequent psychiatric and medical comorbidities, as well as increased mortality. New medications, with improved tolerability profiles, have expanded the treatment armamentarium. Various measures can be taken by physicians to improve treatment and facilitate adherence, including using long-acting injectable formulations of antipsychotic medications in first-episode and multi-episode schizophrenia. In this activity, leading psychiatrists will discuss the available and emerging therapies for the management of schizophrenia, as well as assess individualized treatment strategies that reflect the individual patient’s symptomatic domains, improve adherence, and prevent relapse.

Copyright © Vindico Medical Education | Privacy Policy
856.994.9400 | 6900 Grove Road, Building 100 | Thorofare, New Jersey 08086
A Wyanoke Group Company